Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Balance Sheets

v3.21.2
Condensed Consolidated Balance Sheets - USD ($)
Sep. 30, 2021
Dec. 31, 2020
Current Assets    
Cash and cash equivalents $ 222,319 $ 5,632
Prepaid expenses 25,000
Interest receivable 8,654
Note receivable – related party 25,000
Note receivable, net of discount of $14,470 and $0 as of September 30, 2021 and December 31, 2020 104,530
Total Current Assets 360,503 30,632
Property and equipment, net 1,416
Other Assets    
Due from related party 25,143 20,000
Investment at fair value - related party 4,090,000 1,215,500
Investment at fair value 28,722
Trademark 2,836
Total Other Assets 4,143,865 1,238,336
Total Assets 4,504,368 1,270,384
Current Liabilities    
Accounts payable and accrued expenses 923,680 886,453
Accounts payable - related party 821,659 731,659
Short -term advances - related party 1,673,558 1,266,058
Convertible note payable 25,000
Convertible notes payable - related party, note of debt discount of $5,191 and $0, as of September 30, 2021 and December 31, 2020 168,001 120,000
Notes payable - related party - net of debt discount of $0 and $0 as of September 30, 2021 and December 31, 2020 106,850 106,850
Accumulated losses of unconsolidated investees in excess of investment 176,056 117,578
Note payable – current 134,020
Total Current Liabilities 3,869,804 3,387,618
Long Term Liabilities    
Loans payable, net of current 12,647
Convertible note payable, net of debt discount of $34,020 and $42,525 as of September 30, 2021 and December 31, 2020 465,980 457,475
Total Long Term Liabilities 465,980 470,122
Total Liabilities 4,335,784 3,857,740
Commitments and Contingencies (Note 7)  
Stockholders’ Equity (Deficit)    
Preferred stock, $0.0001 par value, 50,000,000 shares authorized, none issued and outstanding as of September 30, 2021 and December 31, 2020
Common stock, $0.0001 par value: authorized 500,000,000, 21,674,000 and 21,674,000 shares issued and outstanding as of September 30, 2021 and December 31, 2020, respectively 2,167 2,167
Additional paid-in capital 810,048 806,249
Accumulated deficit (576,981) (3,341,830)
Stockholders’ Equity (Deficit) 235,234 (2,533,414)
Non-controlling interest (66,650) (53,942)
Total Stockholders’ Equity (Deficit) 168,584 (2,587,356)
Total Liabilities and Stockholders’ Equity (Deficit) $ 4,504,368 $ 1,270,384